FDA Approval Insights: Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma: With Alex Herrera, MD

Welcome to OncLive On Air®! I'm your host today, Riley Kandel.

OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive covers every angle of

oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, we spoke with Alex Herrera, MD, a professor and chief of the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation, as well as associate medical director of the Briskin Center for Clinical Research, at City of Hope in Duarte, California.

In the exclusive interview, Dr Herrera discussed the March 2026 FDA approval of nivolumab (Opdivo) in combination with doxorubicin, vinblastine, and dacarbazine (AVD) for the treatment of adult and pediatric patients who are 12 years of age and older with previously untreated stage III or IV classical Hodgkin lymphoma. In addition to discussing the approval and where this regimen fits into day-to-day clinical practice, Herrera also dissected data from the phase 3 CA209-8UT/SWOG 1826 study (NCT03907488) that supported the regulatory decision.

_____

That’s all we have for today! Thank you for listening to this episode of OncLive On Air. Check back throughout the week for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive is also on social media. On X and BlueSky, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air, please consider subscribing to our podcast on Apple Podcasts, Spotify, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air.

*OncLive On Air is available on: Apple Podcasts, Spotify, CastBox, Podcast Addict, Podchaser, RadioPublic, and TuneIn.